Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001209191-21-064589

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 36,086 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pizzie Nick CHIEF FINANCIAL OFFICER 2021-11-12 Grant or award · Employee Stock Option (Right to Buy) +36,086 36,086 D
Loading xslF345X03/doc4.xml…